Abstract Viral infections can accelerate chronic liver disease (CLD) progression, yet whether SARS-CoV-2 infection drives worse long-term hepatic outcomes in patients with pre-existing CLD remains unknown. This retrospective cohort study investigated whether SARS-CoV-2 infection was associated with mortality, hepatic decompensation, and abnormal fibrosis-related laboratory markers in patients with pre-existing CLD up to 4.5 years post-infection.
Is this you? As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.
Claim your profile